The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 5, 2004, Pages 499-509

  Ligon, Keith L ^a,b   Alberta, John A ^a   Kho, Alvin T ^a,d   Weiss, Jennifer ^a   Kwaan, Mary R ^b   Nutt, Catherine L ^c   Louis, David N ^c   Stiles, Charles D ^a   Rowitch, David H ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Antibody; Astrocytoma; Glioma; Lineage; Olig2; Progenitor

Indexed keywords

OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OLIG1; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CELL DIFFERENTIATION; CELL LINEAGE; DNA MICROARRAY; GLIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; UNITED STATES;

EID: 2442669017     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.5.499     Document Type: Article

References (48)

1. Reifenberger G, Louis DN. Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 2003;62:111-26
2. van den Bent M, Chinot OL, Cairncross JG. Recent developments in the molecular characterization and treatment of oligodendroglial tumors. Neuro-oncol 2003;5:128-38
3. Cairncross JG, Macdonald DR. Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 1988;23:360-64
4. Kleihues P, Cavenee WK, and International Agency for Research on Cancer. Pathology and genetics of tumours of the nervous system. World Health Organization classification of tumours. Lyon: IARC Press, 2000
5. Louis DN, Holland EC, Cairncross JG. Glioma classification: A molecular reappraisal. Am J Pathol 2001;159:779-86
6. Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: Genetics and biology of a grave matter. Genes Dev 2001;15:1311-33
7. Alvarez-Buylla A, Seri B, Doetsch F. Identification of neural stem cells in the adult vertebrate brain. Brain Res Bull 2002;57:751-78
8. Gage FH. Mammalian neural stem cells. Science 2000;287:1433-38
9. Bailey P, Cushing H. A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. Philadelphia, London [etc.]: J.B. Lippincott Company, 1926
10. Holland EC. Progenitor cells and glioma formation. Curr Opin Neurol 2001;14:683-88
11. Recht L, Jang T, Savarese T, Litofsky NS. Neural stem cells and neuro-oncology: Quo vadis? J Cell Biochem 2003;88:11-19
12. Shoshan Y, Nishiyama A, Chang A, et al. Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors. Proc Natl Acad Sci USA 1999;96:10361-66
13. Dahlstrand J, Collins VP, Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 1992;52:5334-41
14. Rowitch DH, Lu QR, Kessaris N, Richardson WD. An 'oligarchy' rules neural development. Trends Neurosci 2002;25:417-22
15. Zhou Q, Anderson DJ. The bHLH transcription factors OLIG2 and OLIGI couple neuronal and glial subtype specification. Cell 2002;109:61-73
16. Lu QR, Sun T, Zhu Z, et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002;109:75-86
17. Lu QR, Park JK, Noll E, et al. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci USA 2001;98:10851-56
18. Bouvier C, Bartoli C, Aguirre-Cruz L, et al. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells. J Neurosurg 2003;99:344-50
19. Marie Y, Sanson M, Mokhtari K, et al. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 2001;358:298-300
20. Ohnishi A, Sawa H, Tsuda M, et al. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas. J Neuropathol Exp Neurol 2003;62:1052-59
21. Alberta JA, Segal RA. Generation and utilization of phosphorylation state specific antibodies to investigate neuronal signaling pathways. In: Current protocols in neuroscience. New York: John Wiley, 1992
22. Ligon KL, Echelard Y, Assimacopoulos S, et al. Loss of Emx2 function leads to ectopic expression of Wnt1 in the developing telencephalon and cortical dysplasia. Development 2003;130:2275-87
23. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003;63:1602-7
24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-54
25. Press WH. Numerical recipes in C: The art of scientific computing. 2nd ed. Cambridge, New York: Cambridge University Press, 1992
26. Takebayashi H, Yoshida S, Sugimori M, et al. Dynamic expression of basic helix-loop-helix Olig family members: Implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech Dev 2000;99:143-48
27. Marin O, Rubenstein JL. A long, remarkable journey: Tangential migration in the telencephalon. Nat Rev Neurosci 2001;2:780-90
28. Ross SE, Greenberg ME, Stiles CD. Basic helix-loop-helix factors in cortical development. Neuron 2003;39:13-25
29. Novitch BG, Chen AI, Jessell TM. Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron 2001;31:773-89
30. Mizuguchi R, Sugimori M, Takebayashi H, et al. Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of panneuronal and subtype-specific properties of motoneurons. Neuron 2001;31:757-71
31. Zhou Q, Wang S, Anderson DJ. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000;25:331-43
32. Lu QR, Yuk D, Alberta JA, et al. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 2000;25:317-29
33. Park HC, Mehta A, Richardson JS, Appel B. Olig2 is required for zebrafish primary motor neuron and oligodendrocyte development. Dev Biol 2002;248:356-68
34. Bachoo RM, Maher EA, Ligon KL, et al. Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002;1:269-77
35. Rubin JB, Rowitch DH. Medulloblastoma: A problem of developmental biology. Cancer Cell 2002;2:7-8
36. Dai C, Holland EC. Astrocyte differentiation states and glioma formation. Cancer J 2003;9:72-81
37. Noble M, Gutowski N, Bevan K, et al. From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage. Glia 1995;15:222-30
38. Wang J, Jani-Sait SN, Escalon EA, et al. The t(14;21)(ql 1.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci USA 2000;97:3497-502
39. Armstrong RC, Migneault A, Shegog ML, Kim JG, Hudson LD, Hessler RB. High-grade human brain tumors exhibit increased expression of myelin transcription factor 1 (MYT1), a zinc finger DNA-binding protein. J Neuropathol Exp Neurol 1997;56:772-81
40. Beghini A, Magnani I, Roversi G, et al. The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines. Oncogene 2003;22:2581-91
41. Bouvier-Labit C, Liprandi A, Monti G, Pellissier JF, Figarella-Branger D. CD44H is expressed by cells of the oligodendrocyte lineage and by oligodendrogliomas in humans. J Neurooncol 2002;60:127-34
42. Herpers MJ, Ramaekers FC, Aldeweireldt J, Moesker O, Slooff J. Co-expression of glial fibrillary acidic protein- and vimentin-type intermediate filaments in human astrocytomas. Acta Neuropathol (Berl) 1986;70:333-39
43. Landry CF, Verity MA, Cherman L, et al. Expression of oligodendrocytic mRNAs in glial tumors: Changes associated with tumor grade and extent of neoplastic infiltration. Cancer Res 1997;57:4098-104
44. Robinson S, Cohen M, Prayson R, Ransohoff RM, Tabrizi N, Miller RH. Constitutive expression of growth-related oncogene and its receptor in oligodendrogliomas. Neurosurgery 2001;48:864-73; discussion 73-74
45. Xia CL, Du ZW, Liu ZY, Huang Q, Chan WY. A2B5 lineages of human astrocytic tumors and their recurrence. Int J Oncol 2003;23:353-61
46. Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002;39:193-206
47. Marx J. Cancer research. Mutant stem cells may seed cancer. Science 2003;301:1308-10
48. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-28